Mark Redshaw is an Investment Director with a sector focus on Sustainable Nutrition, Healthcare Solutions and Specialty Additives. Mark represents Evonik Venture Capital on the boards of HPNow, OPTIfarm and Vivasure and serves on the Board of Observers at In Ovo.
Mark is based in Germany and has been a member of the founding team of Evonik Venture Capital. During his career at Evonik, Mark held several positions within the Nutrition & Care business of Evonik. This included time responsible for sustainability, heading the Evonik’s global Animal Nutrition Services and running the operative business in Africa and the Middle East. Mark studied agriculture at the University of Reading and received a PhD from the University of Nottingham.